APO RESEARCH · REPORT
Stem Cells
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Product & engineering
Understand the product.
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Selected research
Market Structure
Global Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
Report Includes
Read the full market overview
This report provides an overview of the global Stem Cells market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Stem Cells and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Stem Cells revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Stem Cells market size, projected growth trends, production technologies, key applications, and end-use industries.
Stem Cells Segment by Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Stem Cells Segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Stem Cells Segment by Application
Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Stem Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stem Cells industry.
Chapter 3: Detailed analysis of Stem Cells companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cellsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cell Storage
- Stem Cell Pharmaceutical and Treatment
Applications
- Diseases of the Central Nervous System
- Cardiovascular Disease
- Diabetes
- Cancer
- Genetic Diseases
- Autoimmune Disease
- Bone and Cartilage Repair
- Other
Companies covered
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- Medi-post
- JCR Pharmaceutical
- MolMed
- Pharmicell
- Anterogen
- Takeda (TiGenix)
- CBR
- ViaCord
- Esperite
- LifeCell
- CCBC
- VCANBIO
- BOYA LIFE
- Beike Biotechnology
- International Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Stem Cells Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Stem Cell Storage
- 1.2.3 Stem Cell Pharmaceutical and Treatment
- 1.3 Market Analysis by Application
- 1.3.1 Global Stem Cells Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Diseases of the Central Nervous System
- 1.3.3 Cardiovascular Disease
- 1.3.4 Diabetes
- 1.3.5 Cancer
- 1.3.6 Genetic Diseases
- 1.3.7 Autoimmune Disease
- 1.3.8 Bone and Cartilage Repair
- 1.3.9 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Stem Cells Growth Trends by Region
- 1.5.1 Global Stem Cells Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Stem Cells Market Size by Region (2021-2026)
- 1.5.3 Stem Cells Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Stem Cells Market Dynamics
- 2.1 Stem Cells Industry Trends
- 2.2 Stem Cells Industry Drivers
- 2.3 Stem Cells Industry Opportunities and Challenges
- 2.4 Stem Cells Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Stem Cells Revenue by Company (2021-2026)
- 3.2 Global Stem Cells Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Stem Cells Key Company Head office and Area Served
- 3.4 Global Stem Cells Company, Product Type & Application
- 3.5 Global Stem Cells Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Stem Cells Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2025
- 3.6.3 2025 Stem Cells Tier 1, Tier 2, and Tier 3
4 Stem Cells Market by Type
- 4.1 Global Stem Cells Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Stem Cells Market Size by Type (2021-2032)
- 4.3 Global Stem Cells Market Size Share by Type (2021-2032)
5 Stem Cells Market by Application
- 5.1 Global Stem Cells Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Stem Cells Market Size by Application (2021-2032)
- 5.3 Global Stem Cells Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Osiris Therapeutics
- 6.1.1 Osiris Therapeutics Company Information
- 6.1.2 Osiris Therapeutics Business Overview
- 6.1.3 Osiris Therapeutics Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Osiris Therapeutics Stem Cells Product Portfolio
- 6.1.5 Osiris Therapeutics Recent Developments
- 6.2 NuVasive
- 6.2.1 NuVasive Company Information
- 6.2.2 NuVasive Business Overview
- 6.2.3 NuVasive Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 NuVasive Stem Cells Product Portfolio
- 6.2.5 NuVasive Recent Developments
- 6.3 Chiesi Pharmaceuticals
- 6.3.1 Chiesi Pharmaceuticals Company Information
- 6.3.2 Chiesi Pharmaceuticals Business Overview
- 6.3.3 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
- 6.3.5 Chiesi Pharmaceuticals Recent Developments
- 6.4 Medi-post
- 6.4.1 Medi-post Company Information
- 6.4.2 Medi-post Business Overview
- 6.4.3 Medi-post Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Medi-post Stem Cells Product Portfolio
- 6.4.5 Medi-post Recent Developments
- 6.5 JCR Pharmaceutical
- 6.5.1 JCR Pharmaceutical Company Information
- 6.5.2 JCR Pharmaceutical Business Overview
- 6.5.3 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
- 6.5.5 JCR Pharmaceutical Recent Developments
- 6.6 MolMed
- 6.6.1 MolMed Company Information
- 6.6.2 MolMed Business Overview
- 6.6.3 MolMed Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 MolMed Stem Cells Product Portfolio
- 6.6.5 MolMed Recent Developments
- 6.7 Pharmicell
- 6.7.1 Pharmicell Company Information
- 6.7.2 Pharmicell Business Overview
- 6.7.3 Pharmicell Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Pharmicell Stem Cells Product Portfolio
- 6.7.5 Pharmicell Recent Developments
- 6.8 Anterogen
- 6.8.1 Anterogen Company Information
- 6.8.2 Anterogen Business Overview
- 6.8.3 Anterogen Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Anterogen Stem Cells Product Portfolio
- 6.8.5 Anterogen Recent Developments
- 6.9 Takeda (TiGenix)
- 6.9.1 Takeda (TiGenix) Company Information
- 6.9.2 Takeda (TiGenix) Business Overview
- 6.9.3 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
- 6.9.5 Takeda (TiGenix) Recent Developments
- 6.10 CBR
- 6.10.1 CBR Company Information
- 6.10.2 CBR Business Overview
- 6.10.3 CBR Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CBR Stem Cells Product Portfolio
- 6.10.5 CBR Recent Developments
- 6.11 ViaCord
- 6.11.1 ViaCord Company Information
- 6.11.2 ViaCord Business Overview
- 6.11.3 ViaCord Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 ViaCord Stem Cells Product Portfolio
- 6.11.5 ViaCord Recent Developments
- 6.12 Esperite
- 6.12.1 Esperite Company Information
- 6.12.2 Esperite Business Overview
- 6.12.3 Esperite Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Esperite Stem Cells Product Portfolio
- 6.12.5 Esperite Recent Developments
- 6.13 LifeCell
- 6.13.1 LifeCell Company Information
- 6.13.2 LifeCell Business Overview
- 6.13.3 LifeCell Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 LifeCell Stem Cells Product Portfolio
- 6.13.5 LifeCell Recent Developments
- 6.14 CCBC
- 6.14.1 CCBC Company Information
- 6.14.2 CCBC Business Overview
- 6.14.3 CCBC Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 CCBC Stem Cells Product Portfolio
- 6.14.5 CCBC Recent Developments
- 6.15 VCANBIO
- 6.15.1 VCANBIO Company Information
- 6.15.2 VCANBIO Business Overview
- 6.15.3 VCANBIO Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 VCANBIO Stem Cells Product Portfolio
- 6.15.5 VCANBIO Recent Developments
- 6.16 BOYA LIFE
- 6.16.1 BOYA LIFE Company Information
- 6.16.2 BOYA LIFE Business Overview
- 6.16.3 BOYA LIFE Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 BOYA LIFE Stem Cells Product Portfolio
- 6.16.5 BOYA LIFE Recent Developments
- 6.17 Beike Biotechnology
- 6.17.1 Beike Biotechnology Company Information
- 6.17.2 Beike Biotechnology Business Overview
- 6.17.3 Beike Biotechnology Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Beike Biotechnology Stem Cells Product Portfolio
- 6.17.5 Beike Biotechnology Recent Developments
- 6.18 International Medical
- 6.18.1 International Medical Company Information
- 6.18.2 International Medical Business Overview
- 6.18.3 International Medical Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 International Medical Stem Cells Product Portfolio
- 6.18.5 International Medical Recent Developments
7 North America
- 7.1 North America Stem Cells Market Size (2021-2032)
- 7.2 North America Stem Cells Market Size by Type
- 7.2.1 North America Stem Cells Market Size by Type (2021-2026)
- 7.2.2 North America Stem Cells Market Size by Type (2027-2032)
- 7.2.3 North America Stem Cells Market Share by Type (2021-2032)
- 7.3 North America Stem Cells Market Size by Application
- 7.3.1 North America Stem Cells Market Size by Application (2021-2026)
- 7.3.2 North America Stem Cells Market Size by Application (2027-2032)
- 7.3.3 North America Stem Cells Market Share by Application (2021-2032)
- 7.4 North America Stem Cells Market Size by Country
- 7.4.1 North America Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Stem Cells Market Size by Country (2021-2026)
- 7.4.3 North America Stem Cells Market Size by Country (2027-2032)
- 7.4.4 North America Stem Cells Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Stem Cells Market Size (2021-2032)
- 8.2 Europe Stem Cells Market Size by Type
- 8.2.1 Europe Stem Cells Market Size by Type (2021-2026)
- 8.2.2 Europe Stem Cells Market Size by Type (2027-2032)
- 8.2.3 Europe Stem Cells Market Share by Type (2021-2032)
- 8.3 Europe Stem Cells Market Size by Application
- 8.3.1 Europe Stem Cells Market Size by Application (2021-2026)
- 8.3.2 Europe Stem Cells Market Size by Application (2027-2032)
- 8.3.3 Europe Stem Cells Market Share by Application (2021-2032)
- 8.4 Europe Stem Cells Market Size by Country
- 8.4.1 Europe Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Stem Cells Market Size by Country (2021-2026)
- 8.4.3 Europe Stem Cells Market Size by Country (2027-2032)
- 8.4.4 Europe Stem Cells Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Stem Cells Market Size (2021-2032)
- 9.2 China Stem Cells Market Size by Type
- 9.2.1 China Stem Cells Market Size by Type (2021-2026)
- 9.2.2 China Stem Cells Market Size by Type (2027-2032)
- 9.2.3 China Stem Cells Market Share by Type (2021-2032)
- 9.3 China Stem Cells Market Size by Application
- 9.3.1 China Stem Cells Market Size by Application (2021-2026)
- 9.3.2 China Stem Cells Market Size by Application (2027-2032)
- 9.3.3 China Stem Cells Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Stem Cells Market Size (2021-2032)
- 10.2 Asia Stem Cells Market Size by Type
- 10.2.1 Asia Stem Cells Market Size by Type (2021-2026)
- 10.2.2 Asia Stem Cells Market Size by Type (2027-2032)
- 10.2.3 Asia Stem Cells Market Share by Type (2021-2032)
- 10.3 Asia Stem Cells Market Size by Application
- 10.3.1 Asia Stem Cells Market Size by Application (2021-2026)
- 10.3.2 Asia Stem Cells Market Size by Application (2027-2032)
- 10.3.3 Asia Stem Cells Market Share by Application (2021-2032)
- 10.4 Asia Stem Cells Market Size by Country
- 10.4.1 Asia Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Stem Cells Market Size by Country (2021-2026)
- 10.4.3 Asia Stem Cells Market Size by Country (2027-2032)
- 10.4.4 Asia Stem Cells Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Stem Cells Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Stem Cells Market Size by Type
- 11.2.1 South America, Middle East & Africa Stem Cells Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Stem Cells Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Stem Cells Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Stem Cells Market Size by Application
- 11.3.1 South America, Middle East & Africa Stem Cells Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Stem Cells Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Stem Cells Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Stem Cells Market Size by Country
- 11.4.1 South America, Middle East & Africa Stem Cells Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Stem Cells Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Stem Cells Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Stem Cells Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst